| Price | 4.45p on 30-04-2026 at 18:40:08 |
|---|---|
| Change | 0.00p 0% |
| Buy | 4.70p |
| Sell | 4.20p |
| Last Trade: | Sell 4,100.00 at 4.24p |
| Day's Volume: | 213,286 |
| Last Close: | 4.45p |
| Open: | 4.45p |
| ISIN: | GB00BKPG7Z60 |
| Day's Range | 4.45p - 4.45p |
| 52wk Range: | 2.40p - 5.18p |
| Market Capitalisation: | £31.38m |
| VWAP: | 4.305282p |
| Shares in Issue: | 705.10m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Poolbeg Pharma (POLB) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 4,100 | 4.24p | Ordinary |
16:00:31 - 30-Apr-26 |
| Sell* | 27,006 | 4.24p | Ordinary |
13:06:30 - 30-Apr-26 |
| Sell* | 45,444 | 4.39p | Ordinary |
11:53:40 - 30-Apr-26 |
| Sell* | 1,867 | 4.40p | Ordinary |
09:32:12 - 30-Apr-26 |
| Sell* | 124 | 4.20p | SI Trade |
09:09:01 - 30-Apr-26 |
| Buy* | 115 | 4.70p | SI Trade |
09:09:01 - 30-Apr-26 |
| Buy* | 212 | 4.70p | SI Trade |
09:09:01 - 30-Apr-26 |
| Buy* | 32 | 4.70p | SI Trade |
09:09:01 - 30-Apr-26 |
| Sell* | 138 | 4.20p | SI Trade |
09:09:01 - 30-Apr-26 |
| Buy* | 100 | 4.70p | SI Trade |
09:09:01 - 30-Apr-26 |
Poolbeg Pharma (POLB) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 28th Apr 2026 7:00 am | RNS | Results for the year ended 31 December 2025 |
| 15th Apr 2026 7:00 am | RNS | MHRA grants CTA for the POLB 001 TOPICAL trial |
| 31st Mar 2026 7:00 am | RNS | Significant milestone for Poolbeg's IP portfolio |
| 12th Mar 2026 7:00 am | RNS-R | Appointment of Dr Adrian Kilcoyne to SAB |
| 9th Feb 2026 3:13 pm | RNS | Notification of Major Holdings |
| 28th Jan 2026 7:00 am | RNS | POLB 001 LPS Challenge Trial Paper Published |
| 27th Jan 2026 2:30 pm | RNS | Exercise of Options & Total Voting Rights |
| 18th Dec 2025 7:00 am | RNS-R | Letter to Shareholders – 2025 a year of progress |
| 8th Dec 2025 7:00 am | RNS-R | POLB 001 to feature in CRS research programme |
| 20th Nov 2025 7:00 am | RNS | POLB 001 European Patent granted |
